Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease

NCT04578639 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

214

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Rituximab
DRUG: Ocrelizumab

Sponsor

Haukeland University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]